224 related articles for article (PubMed ID: 1715365)
1. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology.
Massey WA; Guo CB; Dvorak AM; Hubbard WC; Bhagavan BS; Cohan VL; Warner JA; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1991 Sep; 147(5):1621-7. PubMed ID: 1715365
[TBL] [Abstract][Full Text] [Related]
2. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
3. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL
J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587
[TBL] [Abstract][Full Text] [Related]
4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
5. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
6. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
7. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
8. Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungs.
Dvorak AM; Schleimer RP; Schulman ES; Lichtenstein LM
Lab Invest; 1986 Jun; 54(6):663-78. PubMed ID: 2423778
[TBL] [Abstract][Full Text] [Related]
9. Human skin mast cells: their dispersion, purification, and secretory characterization.
Benyon RC; Lowman MA; Church MK
J Immunol; 1987 Feb; 138(3):861-7. PubMed ID: 2433332
[TBL] [Abstract][Full Text] [Related]
10. Histochemical heterogeneity of dispersed human lung mast cells.
Schulman ES; Pollack RB; Post TJ; Peters SP
J Immunol; 1990 Jun; 144(11):4195-201. PubMed ID: 1692857
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of human intestinal mucosal mast cells.
Fox CC; Dvorak AM; Peters SP; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1985 Jul; 135(1):483-91. PubMed ID: 2582045
[TBL] [Abstract][Full Text] [Related]
12. Functional and biochemical characterization of rat bone marrow derived mast cells.
Broide DH; Metcalfe DD; Wasserman SI
J Immunol; 1988 Dec; 141(12):4298-305. PubMed ID: 2974057
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.
Lawrence ID; Warner JA; Cohan VL; Hubbard WC; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1987 Nov; 139(9):3062-9. PubMed ID: 2444649
[TBL] [Abstract][Full Text] [Related]
14. Dissociated human foreskin mast cells degranulate in response to anti-IgE and substance P.
Caulfield JP; el-Lati S; Thomas G; Church MK
Lab Invest; 1990 Oct; 63(4):502-10. PubMed ID: 1700194
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human synovial mast cells.
Kopicky-Burd JA; Kagey-Sobotka A; Peters SP; Dvorak AM; Lennox DW; Lichtenstein LM; Wigley FM
J Rheumatol; 1988 Sep; 15(9):1326-33. PubMed ID: 2462048
[TBL] [Abstract][Full Text] [Related]
16. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
[TBL] [Abstract][Full Text] [Related]
18. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
19. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
20. Release of chemical mediators from partially purified human lung mast cells.
Paterson NA; Wasserman SI; Said JW; Austen KF
J Immunol; 1976 Oct; 117(4):1356-62. PubMed ID: 61999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
